{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:40Z","timestamp":1786119400894,"version":"build-2736575974"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1097\/fpc.0b013e3283339c08","type":"journal-article","created":{"date-parts":[[2009,11,19]],"date-time":"2009-11-19T12:49:42Z","timestamp":1258634982000},"page":"972-978","source":"Crossref","is-referenced-by-count":3,"title":["A mathematical model to improve on phenotyping for molecular genetic research in malignant hyperthermia"],"prefix":"10.1097","volume":"19","author":[{"given":"Hans F.","family":"Ginz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"R\u00fcffert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soledad","family":"Levano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Li Wan Po","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Benthien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Urwyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210214","first-page":"1169","article-title":"Miller's anesthesia. 6th ed","author":"Gronert","year":"2005"},{"key":"R2-7-20210214","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/56.11.1267","article-title":"A protocol for the investigation of malignant hyperpyrexia (MH) susceptibility","volume":"56","year":"1984","journal-title":"Br J Anaesth"},{"key":"R3-7-20210214","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1213\/00000539-198910000-00015","article-title":"Standardization of the caffeine halothane muscle contracture test. North American malignant hyperthermia group","volume":"69","author":"Larach","year":"1989","journal-title":"Anesth Analg"},{"key":"R4-7-20210214","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/humu.20356","article-title":"Mutations in ryr1 in malignant hyperthermia and central core disease","volume":"27","author":"Robinson","year":"2006","journal-title":"Hum Mutat"},{"key":"R5-7-20210214","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1093\/bja\/86.2.283","article-title":"Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia","volume":"86","author":"Urwyler","year":"2001","journal-title":"Br J Anaesth"},{"key":"R6-7-20210214","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1097\/00000542-200402000-00058","article-title":"Malignant hyperthermia genetic testing in North America working group meeting. Bethesda, Maryland. September 4\u20135, 2002","volume":"100","author":"Sei","year":"2004","journal-title":"Anesthesiology"},{"key":"R7-7-20210214","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1097\/00000542-199404000-00008","article-title":"A clinical grading scale to predict malignant hyperthermia susceptibility","volume":"80","author":"Larach","year":"1994","journal-title":"Anesthesiology"},{"key":"R8-7-20210214","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00000542-200201000-00036","article-title":"Testing for malignant hyperthermia","volume":"96","author":"Rosenberg","year":"2002","journal-title":"Anesthesiology"},{"key":"R9-7-20210214","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1002\/humu.20878","article-title":"Increasing the number of diagnostic mutations in malignant hyperthermia","volume":"30","author":"Levano","year":"2009","journal-title":"Hum Mutat"},{"key":"R10-7-20210214","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1034\/j.1399-6576.2002.460610.x","article-title":"Mutation screening in the ryanodine receptor 1 gene (ryr1) in patients susceptible to malignant hyperthermia who show definite ivct results: identification of three novel mutations","volume":"46","author":"Rueffert","year":"2002","journal-title":"Acta Anaesthesiol Scand"},{"key":"R11-7-20210214","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/humu.1203","article-title":"Genotype-phenotype comparison of the swiss malignant hyperthermia population","volume":"18","author":"Girard","year":"2001","journal-title":"Hum Mutat"},{"key":"R12-7-20210214","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1126\/science.3287615","article-title":"Measuring the accuracy of diagnostic systems","volume":"240","author":"Swets","year":"1988","journal-title":"Science"},{"key":"R14-7-20210214","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1399-6576.1997.tb04820.x","article-title":"In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European malignant hyperthermia group","volume":"41","author":"Ording","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"R15-7-20210214","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00003643-200110000-00002","article-title":"Malignant hyperthermia","volume":"18","author":"Wappler","year":"2001","journal-title":"Eur J Anaesthesiol"},{"key":"R16-7-20210214","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/bja\/85.1.118","article-title":"Malignant hyperthermia: advances in clinical management and diagnosis","volume":"85","author":"Hopkins","year":"2000","journal-title":"Br J Anaesth"},{"key":"R17-7-20210214","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/j.1399-6576.2007.01293.x","article-title":"Male preponderance of patients testing positive for malignant hyperthermia susceptibility","volume":"51","author":"Islander","year":"2007","journal-title":"Acta Anaesthesiol Scand"},{"key":"R18-7-20210214","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/sj.ejhg.5200964","article-title":"Recent advances in the diagnosis of malignant hyperthermia susceptibility: how confident can we be of genetic testing?","volume":"11","author":"Robinson","year":"2003","journal-title":"Eur J Hum Genet"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01213011-200912000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:09:27Z","timestamp":1786039767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01213011-200912000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e3283339c08","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}